Life Science Leader Blogs

  1. Inovio Pharmaceuticals Is Doing More Than Just Creating Buzz At BIO CEO 2017
    2/16/2017

    When invited to host the BIO Buzz Center during the 2017 BIO CEO & Investor Conference in New York City on behalf of Life Science Leader magazine, I did not know who I’d be interviewing, just that I’d be doing about five video interviews with a number of industry executives and thought leaders.

  2. What Is BIO’s Focus For 2017 And Beyond? More Buzz From BIO CEO
    2/16/2017

    Hosting the BIO Buzz Center during the 2017 BIO CEO & Investor Conference in New York City on behalf of Life Science Leader magazine provided me the opportunity to conduct five video interviews with a number of industry executives and thought leaders.

  3. From Hospital Research Project To Spark Therapeutics – Just One Of The Companies Creating Buzz At BIO CEO 2017
    2/16/2017

    As host of the BIO Buzz Center during the 2017 BIO CEO & Investor Conference in New York City, Life Science Leader magazine conducted five video interviews with a number of industry executives and thought leaders.

  4. Myovant Sciences CEO Creates Buzz At 2017 BIO CEO & Investor Conference
    2/16/2017

    As host of the BIO Buzz Center during the 2017 BIO CEO & Investor Conference in New York City, Life Science Leader magazine had the opportunity to conduct five video interviews with a number of industry executives and thought leaders.

  5. Reader Engagement Helps Us Fulfill Our Mission … And Feel Good, Too
    2/14/2017

    A few years ago I met Mark Scharenbroich. Thankfully, the award-winning author of Nice Bike — Making Meaningful Connections on the Road of Life ended up contributing a Leadership Lessons article for Life Science Leader magazine.

  6. Leadership Lessons From Chris Ruisi — Author Of "Step Up And Play Big"
    1/30/2017

    We’ve all probably encountered the frustrations related to flight delays and cancellations. I recently experienced the latter while on my way to the 35th Annual J. P. Morgan Healthcare Conference (commonly referred to as JPM) in San Francisco. Although, one positive did come out of my unplanned delay — it afforded me the opportunity to get through a leadership book I had been meaning to read, Step Up And Play Big by Chris Ruisi.

  7. Despite Delays, JPM 2017 Still Pays Off For Me
    1/19/2017

    For the second year in a row my travel plans to the biopharmaceutical industry’s yearly kickoff event — the 35th Annual J. P. Morgan Healthcare Conference in San Francisco —was disrupted by weather. And though I once again arrived a day late, there was still plenty to keep me busy during JPM. For example, I still had the opportunity to sit in breakout Q&A sessions involving Alkermes, BMS, Chimerix, GSK, Mylan NV, and Shire. I witnessed company presentations that included AbbVie, CSL Limited, and IDEXX (just to name a few). I attended keynotes involving the Vice President of the United States, Joe Biden, who provided an update on the Cancer Moonshot initiative. I heard political consultants Karl Rove and James Carville debate the pros and cons of repealing and replacing the Affordable Care Act. I even had the opportunity to hear Juan Enriquez, co-author of Evolving Ourselves, share his insights on the next species of human. And while this may seem like a lot, it really only scratches the surface as to the amount of activity that takes place during JPM in January.

  8. Night Of Light: California Life Science Association (CLSA)
    12/12/2016

    Because I live only a day-trip away from San Francisco, it is convenient for me to travel there for industry events — a trek always accompanied by reflective reveries for the hometown of my film-student days. So, for the third time since June, and with another week scheduled for early January, I am once again city-bound, leaving home mid-day and getting into my hotel in plenty of time to make the 5:30 PM reception for the annual Pantheon Awards dinner, held by the California Life Science Association (CLSA).

  9. Why “Partnering For Cures” Is A Highly Differentiated Experience
    11/30/2016

    Two weeks ago I went to the Partnering For Cures (Nov. 13 – 15) conference at the Grand Hyatt in New York. After the experience, it is almost painful to admit that this was my first time attending. Developed by Faster Cures and the Milken Institute, the conference (now in existence for over eight years) brings together nearly 1,000 leaders from across the research ecosystem. The event’s goal is to forge partnerships dedicated to reducing death and suffering. And while I have attended other conferences that preach partnering, this conference, for some reason, felt distinctly different.

  10. Trump Wins: What Can Pharma Hope For In The Next 4 Years?
    11/18/2016

    On November 14, 2016, Carolyn Johnson posted “Trump just dropped a big hint to the pharmaceutical industry” in a wonkblog for The Washington Post. I shared the article on LinkedIn (receiving over 415 views) noting, “It is very early days, so let’s not get too excited or too concerned. But let’s be aware and strive to be part of the solution for helping patients.” This seemed like a natural fit to share considering a large percentage of my network have close ties to biopharma, and the industry seems to have always been pretty closely linked to politics. This fact was never more apparent than at the industry conference I recently attended.